comparing the effect ofKetamin; Bupivacain and Dexmedetomidine intraperitoneal in controlling the pain after operation in patients are candidates for abdominal hysterectomy

Comparing the effect of Ketamin ; Bupivacain and Dexmedetomidine intraperitoneal in controlling the pain after operation in patients are candidates for abdominal hysterectomy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N130

Enrollment

105

Registered

2020-01-20

Start date

2019-01-10

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal hysterectomy. Prolapse of vaginal vault after hysterectomy

Interventions

Intervention 1: Intervention group 1: The first group will be injected with 0.5 to 0.7 microgram in kilogram dexmedetomidine intraperitoneal. Intervention 2: Intervention group2: The second group will

Eligibility

Sex/Gender

Female

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients are candidates for abdominal hysterectomy ASA class 1 and 2 Age 30 to 70 years No sensitivity to drugs

Exclusion criteria

Exclusion criteria: Emergency patients Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Recovery, 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual analogue of pain.;Amount of drug used. Timepoint: 24 hours after surgery. Method of measurement: Milligram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 68 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026